Seizure incidence among neuromyelitis optica spectrum disorder patients - 29/05/21
, R. Khorvash b, M. Mirbagheri b, H. Nouri b, M. Salari cBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 5 |
| Iconographies | 1 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Background |
Neuromyelitis optica spectrum disorders (NMOSDs) are a group of neuroinflammatory diseases, which mainly affect the optic nerve and spinal cord. NMOSD is an astrocytic channelopathy involving the aquaporin-4 (AQP4) water channels in the central nervous system. Patients can present with seizure attacks as a first manifestation or relapse. However, compared with multiple sclerosis (MS) or myelin oligodendrocyte glycoprotein encephalomyelitis (MOG-EM), seizure attacks are less frequent in NMOSD.
Methods |
In this study, we aimed to find out the incidence of seizure attacks during the disease course of 137 NMOSD patients who were registered in our centre from January 2011 till January 2020. Furthermore, we reviewed the literature for NMOSD cases with seizure attacks during their follow-up, in order to investigate the reason for this low incidence of seizures.
Results |
Only one of our patients (0.72%) experienced an episode of generalised tonic-clonic seizure during his follow-up.
Conclusion |
Reviewing the literature revealed that although seizures are rare in NMOSD, AQP4 disruption possibly increases the risk of seizure attacks. We therefore concluded that the role of AQP4 in seizures is controversial and needs more investigation.
Le texte complet de cet article est disponible en PDF.Keywords : Neuromyelitis optica, Seizure, Aquaporin 4, Astrocyte
Plan
Vol 177 - N° 6
P. 655-659 - juin 2021 Retour au numéro
Article précédent
- FOXP3 rs3761548 gene variant and interleukin-35 serum levels as biomarkers in patients with multiple sclerosis
- A. Kamal, M. Hosny, A. Abd Elwahab, Y. Shawki Kamal, H.S. Shehata, A. Hassan
- High risk of osteoporotic fracture in Parkinson's disease: Meta-analysis, pathophysiology and management
- M. Louvois, S. Ferrero, T. Barnetche, C.H. Roux, V. Breuil
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?